JP2023511686A5 - - Google Patents
Info
- Publication number
- JP2023511686A5 JP2023511686A5 JP2022545136A JP2022545136A JP2023511686A5 JP 2023511686 A5 JP2023511686 A5 JP 2023511686A5 JP 2022545136 A JP2022545136 A JP 2022545136A JP 2022545136 A JP2022545136 A JP 2022545136A JP 2023511686 A5 JP2023511686 A5 JP 2023511686A5
- Authority
- JP
- Japan
- Prior art keywords
- renal
- antigen
- acid sequence
- binding fragment
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062966258P | 2020-01-27 | 2020-01-27 | |
| US62/966,258 | 2020-01-27 | ||
| PCT/EP2021/051753 WO2021151889A1 (en) | 2020-01-27 | 2021-01-26 | ANTI-αVβ8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023511686A JP2023511686A (ja) | 2023-03-22 |
| JP2023511686A5 true JP2023511686A5 (https=) | 2024-01-23 |
| JP7706458B2 JP7706458B2 (ja) | 2025-07-11 |
Family
ID=74561850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022545136A Active JP7706458B2 (ja) | 2020-01-27 | 2021-01-26 | 腎疾患の治療に使用するための抗αｖβ８インテグリン抗体 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20230112035A1 (https=) |
| EP (1) | EP4096785A1 (https=) |
| JP (1) | JP7706458B2 (https=) |
| KR (1) | KR20220132567A (https=) |
| CN (1) | CN115151305A (https=) |
| AR (1) | AR121193A1 (https=) |
| AU (1) | AU2021213403B2 (https=) |
| BR (1) | BR112022014633A2 (https=) |
| CA (1) | CA3167390A1 (https=) |
| CL (1) | CL2022001999A1 (https=) |
| CO (1) | CO2022011661A2 (https=) |
| CR (1) | CR20220392A (https=) |
| EC (1) | ECSP22066085A (https=) |
| IL (1) | IL294814A (https=) |
| MX (1) | MX2022009165A (https=) |
| PH (1) | PH12022551863A1 (https=) |
| TW (1) | TWI854088B (https=) |
| WO (1) | WO2021151889A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7654539B2 (ja) | 2018-09-07 | 2025-04-01 | ファイザー・インク | 抗αｖβ８抗体、組成物及びその使用 |
| EP4587473A1 (en) | 2022-09-12 | 2025-07-23 | Institut National de la Santé et de la Recherche Médicale | New anti-itgb8 antibodies and its uses thereof |
| CN120936626A (zh) * | 2023-03-31 | 2025-11-11 | 基因泰克公司 | 抗αvβ8整合素抗体及使用方法 |
| CN117143241B (zh) * | 2023-10-26 | 2024-02-23 | 迈威(上海)生物科技股份有限公司 | 与人整合素蛋白itgav/itgb8特异性结合的单克隆抗体 |
| CN117126282B (zh) * | 2023-10-26 | 2024-01-12 | 迈威(上海)生物科技股份有限公司 | 抗体及其在制备阻断αvβ8与Latent TGF-β的结合的药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| AU2011217848B8 (en) | 2010-02-18 | 2015-09-24 | The Regents Of The University Of California | Integrin aVB8 neutralizing antibody |
| KR102010098B1 (ko) * | 2011-08-17 | 2019-08-13 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 인테그린 알파-v 베타-8에 결합하는 항체 |
| EP3139957A4 (en) * | 2014-05-06 | 2018-04-25 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
| SI3157561T1 (sl) | 2014-06-17 | 2020-08-31 | Medlmmune Limited | Izboljšana protitelesa alfa-V beta-8 |
| EP3634485A4 (en) * | 2017-06-07 | 2021-07-21 | Silverback Therapeutics, Inc. | CONJUGATES OF ANTIBODIES CONTAINING IMMUNOMODULATOR COMPOUNDS AND THEIR USES |
| AU2019318538B2 (en) * | 2018-08-08 | 2025-02-06 | The General Hospital Corporation | Polypeptide integrin antagonists |
-
2021
- 2021-01-13 TW TW110101209A patent/TWI854088B/zh active
- 2021-01-26 CN CN202180010557.1A patent/CN115151305A/zh active Pending
- 2021-01-26 IL IL294814A patent/IL294814A/en unknown
- 2021-01-26 MX MX2022009165A patent/MX2022009165A/es unknown
- 2021-01-26 BR BR112022014633A patent/BR112022014633A2/pt unknown
- 2021-01-26 CR CR20220392A patent/CR20220392A/es unknown
- 2021-01-26 US US17/759,388 patent/US20230112035A1/en active Pending
- 2021-01-26 PH PH1/2022/551863A patent/PH12022551863A1/en unknown
- 2021-01-26 EP EP21703839.7A patent/EP4096785A1/en active Pending
- 2021-01-26 AU AU2021213403A patent/AU2021213403B2/en active Active
- 2021-01-26 CA CA3167390A patent/CA3167390A1/en active Pending
- 2021-01-26 WO PCT/EP2021/051753 patent/WO2021151889A1/en not_active Ceased
- 2021-01-26 JP JP2022545136A patent/JP7706458B2/ja active Active
- 2021-01-26 KR KR1020227028722A patent/KR20220132567A/ko active Pending
- 2021-01-27 AR ARP210100199A patent/AR121193A1/es unknown
-
2022
- 2022-07-25 CL CL2022001999A patent/CL2022001999A1/es unknown
- 2022-08-18 CO CONC2022/0011661A patent/CO2022011661A2/es unknown
- 2022-08-23 EC ECSENADI202266085A patent/ECSP22066085A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023511686A5 (https=) | ||
| JP2022534020A5 (https=) | ||
| JP2020503362A5 (https=) | ||
| CN113874073A (zh) | 用针对IL-23和TNFα的抗体的联合疗法治疗炎性肠病的方法 | |
| JP2019511911A5 (https=) | ||
| CA2583910A1 (en) | Angiopoietin-2 specific binding agents | |
| JP2006020633A (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| RU2015136078A (ru) | Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний | |
| JPWO2020059847A5 (https=) | ||
| JP2008529489A5 (https=) | ||
| JP2017536111A5 (https=) | ||
| JP2017507131A5 (https=) | ||
| JP2015509948A5 (https=) | ||
| JP2016515120A5 (https=) | ||
| JP2015504073A5 (https=) | ||
| JP2014530244A5 (https=) | ||
| JP2022505585A5 (https=) | ||
| JP2019533426A5 (https=) | ||
| JP2022515480A (ja) | 掌蹠膿疱症の処置のための抗ｉｌ－３６ｒ抗体 | |
| JP2019528285A5 (https=) | ||
| JP2019528306A5 (https=) | ||
| JP2018529661A5 (https=) | ||
| JP2022533855A5 (https=) | ||
| JP2022502024A5 (https=) | ||
| CN116199795B (zh) | 融合蛋白及其用途 |